BRCA1 and head and neck squamous cell carcinoma: Somatic mutations in BRCA1 are seen in only 6% and BRCA 2 in 7% of head and neck squamous cell carcinoma (HNSCC) patients, indicating the multistep process involved in tumorigenesis.